BNP Paribas Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3M Buy
1,060,806
+101,512
+11% +$3.46M 0.04% 456
2025
Q4
$38M Buy
959,294
+192,156
+25% +$7.04M 0.04% 367
2025
Q3
$27M Buy
767,138
+11,601
+2% +$400K 0.07% 279
2025
Q2
$24.8M Buy
755,537
+7,731
+1% +$251K 0.06% 305
2025
Q1
$24.1M Buy
747,806
+147,000
+24% +$5.46M 0.06% 292
2024
Q4
$18.4M Buy
600,806
+100,157
+20% +$3.22M 0.05% 367
2024
Q3
$14M Buy
500,649
+119,929
+32% +$2.96M 0.03% 378
2024
Q2
$8.67M Buy
380,720
+2,898
+0.8% +$66.9K 0.02% 444
2024
Q1
$11.5M Sell
377,822
-78,940
-17% -$2.64M 0.03% 407
2023
Q4
$16.3M Sell
456,762
-38,711
-8% -$1.44M 0.05% 327
2023
Q3
$21.7M Buy
495,473
+14,199
+3% +$693K 0.07% 278
2023
Q2
$23.8M Sell
481,274
-148,124
-24% -$6.83M 0.07% 262
2023
Q1
$26.1M Buy
629,398
+26,617
+4% +$1.1M 0.09% 239
2022
Q4
$26.8M Buy
602,781
+102,977
+21% +$4.3M 0.1% 246
2022
Q3
$19.5M Buy
499,804
+31,717
+7% +$1.45M 0.08% 284
2022
Q2
$19.1M Buy
468,087
+30,542
+7% +$1.45M 0.07% 293
2022
Q1
$28.7M Sell
437,545
-23,725
-5% -$1.54M 0.1% 240
2021
Q4
$32.1M Buy
461,270
+29,582
+7% +$2.15M 0.11% 232
2021
Q3
$30M Buy
431,688
+51,000
+13% +$3.92M 0.11% 218
2021
Q2
$30.2M Sell
380,688
-81,425
-18% -$5.92M 0.11% 235
2021
Q1
$30.3M Sell
462,113
-147,273
-24% -$9.07M 0.12% 196
2020
Q4
$33.9M Buy
609,386
+79,637
+15% +$3.44M 0.16% 162
2020
Q3
$21.1M Buy
529,749
+126,244
+31% +$5.35M 0.12% 211
2020
Q2
$18.1M Sell
403,505
-164,894
-29% -$7.18M 0.12% 201
2020
Q1
$19.1M Sell
568,399
-83,430
-13% -$3M 0.16% 173
2019
Q4
$21.2M Buy
651,829
+90,287
+16% +$2.57M 0.15% 196
2019
Q3
$14M Buy
561,542
+52,366
+10% +$1.5M 0.11% 242
2019
Q2
$15.2M Buy
509,176
+72,154
+17% +$2.11M 0.12% 223
2019
Q1
$11.7M Buy
437,022
+108,788
+33% +$3.3M 0.1% 260
2018
Q4
$9.79M Buy
+328,234
New +$10.2M 0.09% 290

Other funds holding ATRC

BNP Paribas Asset Management's ATRC Position: Q1 2026 in Review

BNP Paribas Asset Management increased its AtriCure (ATRC) stake by 11% in Q1 2026, buying an estimated $3.46M and bringing the position to 1,060,806 shares worth $30.3M. The position accounts for 0.04% of the portfolio, ranked #456.

BNP Paribas Asset Management first reported a position in ATRC in Q4 2018 and has held it in 30 quarters since. The position peaked at $38M in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • BNP Paribas Asset Management held 1,060,806 shares of AtriCure worth $30.3M as of Q1 2026.
  • BNP Paribas Asset Management bought 101,512 AtriCure shares in Q1 2026, an estimated $3.46M.
  • AtriCure made up 0.04% of BNP Paribas Asset Management's portfolio in Q1 2026, its #456 holding.
  • BNP Paribas Asset Management first reported a position in AtriCure in Q4 2018 and has held it in 30 quarters since.
  • BNP Paribas Asset Management's AtriCure position peaked at $38M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.